NO20080372L - Pyrazole derivatives as therapeutic agents - Google Patents
Pyrazole derivatives as therapeutic agentsInfo
- Publication number
- NO20080372L NO20080372L NO20080372A NO20080372A NO20080372L NO 20080372 L NO20080372 L NO 20080372L NO 20080372 A NO20080372 A NO 20080372A NO 20080372 A NO20080372 A NO 20080372A NO 20080372 L NO20080372 L NO 20080372L
- Authority
- NO
- Norway
- Prior art keywords
- therapeutic agents
- pyrazole derivatives
- diarylpyrazole
- carboxamides
- psychiatric
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Endocrinology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Psychology (AREA)
- Obesity (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Addiction (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Child & Adolescent Psychology (AREA)
- Reproductive Health (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Salter av 1,5-diarylpyrazol-3-karboksamider og prosesser for fremstilling av slike forbindelser, anvendelse av dem ved behandling av fedme, psykiatriske og nevrologiske lidelser, til metoder for deres terapeutiske anvendelse og til farmasøytiske preparater inneholdende dem.Salts of 1,5-diarylpyrazole-3-carboxamides and processes for the preparation of such compounds, their use in the treatment of obesity, psychiatric and neurological disorders, to methods of their therapeutic use and to pharmaceutical preparations containing them.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0516661.6A GB0516661D0 (en) | 2005-08-13 | 2005-08-13 | Therapeutic agents |
PCT/GB2006/002990 WO2007020388A1 (en) | 2005-08-13 | 2006-08-09 | Pyrazole derivatives as therapeutic agents |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20080372L true NO20080372L (en) | 2008-04-16 |
Family
ID=35098275
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20080372A NO20080372L (en) | 2005-08-13 | 2008-01-21 | Pyrazole derivatives as therapeutic agents |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP1915364A1 (en) |
JP (1) | JP2009504717A (en) |
KR (1) | KR20080039939A (en) |
CN (1) | CN101282963A (en) |
AR (1) | AR055368A1 (en) |
AU (1) | AU2006281300A1 (en) |
BR (1) | BRPI0614626A2 (en) |
CA (1) | CA2619228A1 (en) |
EC (1) | ECSP088250A (en) |
GB (1) | GB0516661D0 (en) |
IL (1) | IL188759A0 (en) |
MX (1) | MX2008002065A (en) |
NO (1) | NO20080372L (en) |
RU (1) | RU2008108179A (en) |
TW (1) | TW200728300A (en) |
UY (1) | UY29741A1 (en) |
WO (1) | WO2007020388A1 (en) |
ZA (1) | ZA200800698B (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102008015033A1 (en) | 2008-03-17 | 2009-09-24 | Aicuris Gmbh & Co. Kg | Substituted (pyrazolyl-carbonyl) imidazolidinones and their use |
DE102008015032A1 (en) | 2008-03-17 | 2009-09-24 | Aicuris Gmbh & Co. Kg | Substituted pyrazolamides and their use |
DE102008062863A1 (en) | 2008-12-17 | 2010-06-24 | Aicuris Gmbh & Co. Kg | Substituted (thiophenyl-carbonyl) imidazolidinones and their use |
DE102008062878A1 (en) | 2008-12-17 | 2010-06-24 | Aicuris Gmbh & Co. Kg | Substituted furancarboxamides and their use |
DE102009036604A1 (en) | 2009-07-30 | 2011-02-03 | Aicuris Gmbh & Co. Kg | Substituted bis-arylpyrazolamides with terminal primary amide functionality and their use |
DE102011055815A1 (en) | 2011-11-29 | 2013-05-29 | Aicuris Gmbh & Co. Kg | Carboxamide-substituted heteroaryl-pyrazoles and their use |
DE102012016908A1 (en) | 2012-08-17 | 2014-02-20 | Aicuris Gmbh & Co. Kg | Tris (hetero) aryl-pyrazoles and their use |
CN105061227A (en) * | 2015-07-27 | 2015-11-18 | 广东先强药业有限公司 | Environment-friendly ritodrine hydrochloride production method |
US11548875B2 (en) | 2018-12-12 | 2023-01-10 | University Of Washington | Inhibitor compounds for male contraception |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL377778A1 (en) * | 2002-12-02 | 2006-02-20 | Astellas Pharma Inc. | Pyrazole derivatives |
US7247628B2 (en) * | 2002-12-12 | 2007-07-24 | Pfizer, Inc. | Cannabinoid receptor ligands and uses thereof |
KR20060131906A (en) * | 2004-02-20 | 2006-12-20 | 아스트라제네카 아베 | 3-substituted 1,5-diphenylpyrazole derivatives useful as cb1 modulators |
-
2005
- 2005-08-13 GB GBGB0516661.6A patent/GB0516661D0/en not_active Ceased
-
2006
- 2006-08-01 TW TW095128062A patent/TW200728300A/en unknown
- 2006-08-08 AR ARP060103449A patent/AR055368A1/en unknown
- 2006-08-09 KR KR1020087004570A patent/KR20080039939A/en not_active Application Discontinuation
- 2006-08-09 WO PCT/GB2006/002990 patent/WO2007020388A1/en active Application Filing
- 2006-08-09 BR BRPI0614626-0A patent/BRPI0614626A2/en not_active Application Discontinuation
- 2006-08-09 JP JP2008526536A patent/JP2009504717A/en active Pending
- 2006-08-09 EP EP06779114A patent/EP1915364A1/en not_active Withdrawn
- 2006-08-09 AU AU2006281300A patent/AU2006281300A1/en not_active Abandoned
- 2006-08-09 RU RU2008108179/04A patent/RU2008108179A/en not_active Application Discontinuation
- 2006-08-09 CA CA002619228A patent/CA2619228A1/en not_active Abandoned
- 2006-08-09 MX MX2008002065A patent/MX2008002065A/en not_active Application Discontinuation
- 2006-08-09 CN CNA2006800374501A patent/CN101282963A/en active Pending
- 2006-08-11 UY UY29741A patent/UY29741A1/en not_active Application Discontinuation
-
2008
- 2008-01-14 IL IL188759A patent/IL188759A0/en unknown
- 2008-01-21 NO NO20080372A patent/NO20080372L/en not_active Application Discontinuation
- 2008-01-23 ZA ZA200800698A patent/ZA200800698B/en unknown
- 2008-03-07 EC EC2008008250A patent/ECSP088250A/en unknown
Also Published As
Publication number | Publication date |
---|---|
ZA200800698B (en) | 2009-01-28 |
AR055368A1 (en) | 2007-08-22 |
CN101282963A (en) | 2008-10-08 |
MX2008002065A (en) | 2008-04-16 |
EP1915364A1 (en) | 2008-04-30 |
WO2007020388A1 (en) | 2007-02-22 |
ECSP088250A (en) | 2008-04-28 |
GB0516661D0 (en) | 2005-09-21 |
CA2619228A1 (en) | 2007-02-22 |
AU2006281300A1 (en) | 2007-02-22 |
RU2008108179A (en) | 2009-09-20 |
TW200728300A (en) | 2007-08-01 |
BRPI0614626A2 (en) | 2012-12-04 |
JP2009504717A (en) | 2009-02-05 |
IL188759A0 (en) | 2008-08-07 |
UY29741A1 (en) | 2007-03-30 |
KR20080039939A (en) | 2008-05-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20080372L (en) | Pyrazole derivatives as therapeutic agents | |
NO20080969L (en) | 1,2-diarylimidazoles for use as CBI modulators | |
NO20064974L (en) | therapeutic agents | |
NO20063787L (en) | Therapeutic preparations | |
NO20055919L (en) | 3-Substituted, 5,6-Diaryl-Pyrazine-2-Carboxamide and 2-Sulfonamide Derivatives as CB1 Modulators | |
TW200635903A (en) | Therapeutic agents | |
NO20045301L (en) | Substituted 1,3-diphenylprop-2-en-1-one derivative, preparation and use thereof. | |
NO20064201L (en) | Glucopyranosyl substituted benzene derivatives, drugs containing such compounds, their use and preparation | |
TW200504034A (en) | Therapeutic agents | |
NO20081523L (en) | Preparation and Use of Tetrahydropyrrolo (3,2-C) Pyridin-4-One Derivatives for the Treatment of Obesity, Psychiatric and Neurological Disorders | |
NO20084496L (en) | Pyridyl and pyrimidinyl substituted pyrrole, thiophene and furan derivatives as kinase inhibitors | |
DK1791830T3 (en) | Diaminotriazole compounds useful as protein kinase inhibitors | |
TW200633986A (en) | Therapeutic agents | |
TNSN06053A1 (en) | 6-substituted anilino purines as rtk inhibitors | |
NO20085373L (en) | P38 inhibitors, their preparation and use | |
DK1636236T3 (en) | Pyrazolo-quinazoline derivatives, a process for their preparation, and their use as kinase inhibitors | |
TW200615266A (en) | Organic compounds | |
NO20082508L (en) | Aminopyrimidines useful as kinase inhibitors | |
WO2008002245A8 (en) | Imidazol-pyrimidine derivatives for treatment of diseases related to glycogen synthase kinase (gsk3) | |
NO20070576L (en) | New hydantion derivatives for the treatment of obstructive airway diseases. | |
NO20084747L (en) | Tetrahydropteridines useful as inhibitors of protein kinases | |
NO20082496L (en) | pyrazine derivatives | |
NO20065936L (en) | Sulfonylethyl phosphorus diamides for use in the treatment of cancer. | |
NO20081844L (en) | Therapeutic compounds | |
NO20070570L (en) | Compounds. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |